L'intérêt à découvert pour Darling Ingredients donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de Darling Ingredients. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

Darling Ingredients (NYSE:DAR) Stock, Rapport sur les intérêts à découvert

Darling Ingredients

Darling Ingredients Inc develops and manufactures sustainable ingredients for customers in the pharmaceutical, food, pet food, fuel, and fertilizer industries. It collects and transforms all aspects of animal by-product streams into ingredients, including gelatin, fats, proteins, pet food ingredients, fertilizers. Also, the company recovers and converts used cooking oil and bakery remnants into feed and fuel ingredients. Darling has three primary business segments which are feed ingredients contributing the majority of revenue, food ingredients, and fuel ingredients. It provides grease trap services for food businesses and sells various equipment for collecting and delivering cooking oil. The company derives the majority of its revenue from customers in North America.

Darling Ingredients Inc

Mines of Dalarnia - United States dollar

Dare Bioscience Inc

Grizzle Growth ETF

DIGITAL ARTS INC by Digital Arts Inc.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Baird analyst Ben Kallo downgraded Darling Ingredients Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>) from Outperform to Neutral and slashed the price target from $40 to $36. Darling Ingredients shares closed at $35.19 on Thursday. <a href="https://www.benzinga.com/quote/dar/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Evercore ISI Group analyst Eric Boyes downgraded the rating for Dow Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>) from Outperform to In-Line and lowered the price target from $56 to $32. Dow shares closed at $25.07 on Thursday. <a href="https://www.benzinga.com/quote/dow/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stifel analyst Jonathan Block downgraded Henry Schein, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSIC#NASDAQ">HSIC</a>) from Buy to Hold and cut the price target from $80 to $75. Henry Schein shares closed at $72.62 on Thursday. <a href="https://www.benzinga.com/quote/hsic/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wolfe Research analyst Keith Stanley downgraded the rating for Plains All American Pipeline, L.P. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAA#NASDAQ">PAA</a>) from Outperform to Peer Perform. Plains All American shares closed at $18.93 on Thursday. <a href="https://www.benzinga.com/quote/paa/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Stephanie Moore downgraded Norfolk Southern Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSC#NYSE">NSC</a>) from Buy to Hold and announced a $300 price target. Norfolk Southern shares closed at $278.00 on Thursday. <a href="https://www.benzinga.com/quote/nsc/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying NSC stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="587" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/25083952/image-400-1024x587.png" alt="" class="wp-image-1000735" style="width:642px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/25083952/image-400-1024x587.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/25083952/image-400-300x172.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/25083952/image-400-768x440.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/25083952/image-400.png 1105w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/07/46599936/top-2-tech-stocks-you-may-want-to-dump-this-quarter">Top 2 Tech Stocks You May Want To Dump This Quarter</a></li>
</ul>
Photo via Shutterstock

News

Downgrades

Pre-Market Outlook

Analyst Ratings

Trading Ideas

HSIC

This Norfolk Southern Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Baird analyst Ben Kallo downgrades Darling Ingredients (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>) from Outperform to Neutral and lowers the price target from $40 to $36.

Price Target

Baird Downgrades Darling Ingredients to Neutral, Lowers Price Target to $36

WIIM

Darling Ingredients shares are trading lower after the company reported worse-than-expected Q2 financial results.

Earnings

Earnings Misses

UPDATE: Darling Ingredients Q2 Adj. EPS $0.09 Misses $0.37 Estimate. Adjusted EPS Excludes Loss On Early Retirement Of Debt Of $0.01/Share

Darling Ingredients Says Due To Uncertainty Concerning Small Refinery Exemptions In Renewable Fuel Standard And Delayed Reaction From RIN Pricing, It Has Lowered FY25 Adjusted EBITDA Outlook From $1.25B-$1.30B To $1.05B-$1.10B

Darling Ingredients Says Global Tariffs Continue To Present Supply Chain Disruptions And Uncertainty

Darling Ingredients (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>) reported quarterly earnings of $0.08 per share which missed the analyst consensus estimate of $0.38 by 78.72 percent. This is a 83.67 percent decrease over earnings of $0.49 per share from the same period last year. The company reported quarterly sales of $1.481 billion which missed the analyst consensus estimate of $1.491 billion by 0.70 percent. This is a 1.79 percent increase over sales of $1.455 billion the same period last year.

Darling Ingredients Q2 EPS $0.08 Misses $0.38 Estimate, Sales $1.481B Miss $1.491B Estimate

ALEX

ALLE

AMAL

AMBP

AMSF

ASPS

BELFA

BELFB

BHLB

BWMX

CIVB

COKE

COLB

COUR

CUBI

DAIO

DCOM

DECK

DGICA

DGICB

ENSG

ENVA

FBIZ

FCFS

FFBC

FFIC

FINW

FISI

FLEX

FRST

GBCI

GLPI

HFWA

IBCP

IMAX

INTC

IRDM

ITGR

JAKK

KNSL

LADR

LARK

LBRT

Laboratory Corporation Of America Holdings

MBLY

MGRC

MOFG

MSBI

MTLS

MYFW

Earnings Scheduled For July 24, 2025

Darling Ingredients (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>) will release its quarterly earnings report on Thursday, 2025-07-24. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Darling Ingredients to report an earnings per share (EPS) of $0.25.
Investors in Darling Ingredients are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Overview of Past Earnings</h3>
The company's EPS missed by $0.32 in the last quarter, leading to a 4.7% increase in the share price on the following day.
Here's a look at Darling Ingredients's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.16</td>
<td>0.48</td>
<td>0.40</td>
<td>0.45</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.16</td>
<td>0.63</td>
<td>0.11</td>
<td>0.49</td>
</tr>
<tr>
<td>Price Change %</td>
<td>5.0%</td>
<td>3.0%</td>
<td>4.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753293702_0.png" alt="eps graph" />
<h3>Market Performance of Darling Ingredients's Stock</h3>
Shares of Darling Ingredients were trading at $36.16 as of July 22. Over the last 52-week period, shares are down 7.05%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<h3>Analyst Views on Darling Ingredients</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Darling Ingredients.
With 2 analyst ratings, Darling Ingredients has a consensus rating of Buy. The average one-year price target is $43.0, indicating a potential 18.92% upside.
<h3>Comparing Ratings Among Industry Peers</h3>
In this analysis, we delve into the analyst ratings and average 1-year price targets of Ingredion, Limoneira and S&amp;W Seed, three key industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for Ingredion, with an average 1-year price target of $151.0, suggesting a potential 317.59% upside.</li>
<li>Analysts currently favor an Buy trajectory for Limoneira, with an average 1-year price target of $23.0, suggesting a potential 36.39% downside.</li>
<li>Analysts currently favor an Buy trajectory for S&amp;W Seed, with an average 1-year price target of $25.0, suggesting a potential 30.86% downside.</li>
</ul>
<h3>Peer Metrics Summary</h3>
Within the peer analysis summary, vital metrics for Ingredion, Limoneira and S&amp;W Seed are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Darling Ingredients</td>
<td>Buy</td>
<td>-2.80%</td>
<td>$311.35M</td>
<td>-0.59%</td>
</tr>
<tr>
<td>Ingredion</td>
<td>Neutral</td>
<td>-3.67%</td>
<td>$466M</td>
<td>5.00%</td>
</tr>
<tr>
<td>Limoneira</td>
<td>Buy</td>
<td>-21.27%</td>
<td>$2.41M</td>
<td>-2.01%</td>
</tr>
<tr>
<td>S&amp;W Seed</td>
<td>Buy</td>
<td>1.97%</td>
<td>$3.61M</td>
<td>-8.49%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Darling Ingredients ranks at the bottom for Revenue Growth among its peers. It is also at the bottom for Gross Profit. However, it is at the top for Return on Equity.
<h3>Discovering Darling Ingredients: A Closer Look</h3>
Darling Ingredients Inc develops and manufactures sustainable ingredients for customers in the pharmaceutical, food, pet food, fuel, and fertilizer industries. It collects and transforms all aspects of animal by-product streams into ingredients, including gelatin, fats, proteins, pet food ingredients, fertilizers. Also, the company recovers and converts used cooking oil and bakery remnants into feed and fuel ingredients. Darling has three primary business segments which are feed ingredients contributing the majority of revenue, food ingredients, and fuel ingredients. It provides grease trap services for food businesses and sells various equipment for collecting and delivering cooking oil. The company derives the majority of its revenue from customers in North America.
<h3>Darling Ingredients's Financial Performance</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Challenges: Darling Ingredients's revenue growth over 3 months faced difficulties. As of 31 March, 2025, the company experienced a decline of approximately -2.8%. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Darling Ingredients's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of -1.89%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Darling Ingredients's ROE excels beyond industry benchmarks, reaching -0.59%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Darling Ingredients's ROA stands out, surpassing industry averages. With an impressive ROA of -0.26%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Darling Ingredients's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.93, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<a href="https://www.benzinga.com/quote/DAR/earnings">To track all earnings releases for Darling Ingredients visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Uncovering Potential: Darling Ingredients's Earnings Preview

Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Darling Ingredients (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>) in the last three months.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $42.75, a high estimate of $46.00, and a low estimate of $40.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 6.04%. 
<img src="https://www.benzinga.com/files/images/story/2025/1751922016_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of Darling Ingredients among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lloyd Byrne</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$46.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Ben Kallo</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$40.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Thomas Palmer</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$44.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Ben Kallo</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$41.00</td>
<td>$51.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Darling Ingredients. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Darling Ingredients compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Darling Ingredients's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/DAR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Darling Ingredients analyst ratings.</a>
<h2>Unveiling the Story Behind Darling Ingredients</h2>
Darling Ingredients Inc develops and manufactures sustainable ingredients for customers in the pharmaceutical, food, pet food, fuel, and fertilizer industries. It collects and transforms all aspects of animal by-product streams into ingredients, including gelatin, fats, proteins, pet food ingredients, fertilizers. Also, the company recovers and converts used cooking oil and bakery remnants into feed and fuel ingredients. Darling has three primary business segments which are feed ingredients contributing the majority of revenue, food ingredients, and fuel ingredients. It provides grease trap services for food businesses and sells various equipment for collecting and delivering cooking oil. The company derives the majority of its revenue from customers in North America.
<h3>Darling Ingredients: A Financial Overview</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Negative Revenue Trend: Examining Darling Ingredients's financials over 3M reveals challenges. As of 31 March, 2025, the company experienced a decline of approximately -2.8% in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Darling Ingredients's net margin excels beyond industry benchmarks, reaching -1.89%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of -0.59%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Darling Ingredients's ROA stands out, surpassing industry averages. With an impressive ROA of -0.26%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Darling Ingredients's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.93, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>Analyst Ratings: What Are They?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 4 Analysts Discuss Darling Ingredients Stock

Jefferies analyst Lloyd Byrne maintains Darling Ingredients (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>) with a Buy and raises the price target from $45 to $46.

Jefferies Maintains Buy on Darling Ingredients, Raises Price Target to $46

Darling Ingredients shares are trading higher after the company announced it launched a €750 million debt offering.

U.S. stocks were higher, with the Dow Jones index gaining around 500 points on Monday.
Shares of Sage Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAGE#NASDAQ">SAGE</a>) rose sharply during Monday's session after Supernus Pharmaceuticals <a href="https://www.benzinga.com/quote/SAGE">agreed to acquire the company</a>.
Supernus Pharmaceuticals on Monday agreed to acquire Sage Therapeutics for $12.00 per share in cash, or an aggregate of up to approximately $795 million.
The deal consideration includes $8.50 per share in cash (or an aggregate of approximately $561 million) plus one non-tradable contingent value right (CVR) collectively worth up to $3.50 per share in cash (or an aggregate of approximately $234 million).
Sage Therapeutics shares climbed 35.6% to $9.09 on Monday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>EchoStar Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATS#NASDAQ">SATS</a>) shares jumped 48.2% to $24.96 after President Trump reportedly urged Ergen and Carr to cut a deal on the company&#8217;s spectrum.</li>
<li>AIRO Group Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRO#NASDAQ">AIRO</a>) jumped 42% to $31.11 after jumping 140% on Friday. AIRO Group priced its $60 million initial public offering of 6 million common shares at $10 per share.</li>
<li>Circle Internet Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRCL#NYSE">CRCL</a>) gained 22.1% to $163.13.</li>
<li>Arqit Quantum Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARQQ#NASDAQ">ARQQ</a>) rose 21% to $28.77.</li>
<li>NANO Nuclear Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) gained 17.4% to $35.83. NANO Nuclear Energy announced that Matthew Barry has joined the Company as its Director of Investor Relations.</li>
<li>TSS, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSSI#NASDAQ">TSSI</a>) rose 17.4% to $21.63.</li>
<li>TMC the metals company Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMC#NASDAQ">TMC</a>) rose 17.1% to $5.08 after Korea Zinc announced an equity investment of $85.2 million in the company.</li>
<li>UroGen Pharma Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URGN#NASDAQ">URGN</a>) climbed 17% to $14.05.</li>
<li>Quantum Computing Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) surged 15.6% to $19.17.</li>
<li>NextNav Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NN#NASDAQ">NN</a>) gained 15.6% to $14.88.</li>
<li>Roku, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) rose 10.3% to $82.06 after the company announced a new integration with Amazon Ads.</li>
<li>Hims &amp; Hers Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) gained 10.2% to $61.17.</li>
<li>AST SpaceMobile, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) rose 10% to $42.21.</li>
<li>Uranium Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UEC#NYSE">UEC</a>) gained 9.8% to $6.87.</li>
<li>Newell Brands Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWL#NASDAQ">NWL</a>) rose 9.5% to $5.74.</li>
<li>Darling Ingredients Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>) gained 9.1% to $39.28. Darling Ingredients announced offering of €750 Million of senior notes by Darling Global Finance B.V. and proposed entry into a new amended and restated credit agreement.</li>
<li>MP Materials Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MP#NYSE">MP</a>) rose 9% to $33.42.</li>
<li>Advanced Micro Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) surged 8.5% to $126.01.</li>
<li>The Estée Lauder Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) gained 7.9% to $72.67.</li>
<li>Marvell Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) climbed 6% to $71.15. Marvell Technology announced a quarterly dividend of 6 cents per share of common stock.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/45946608/top-3-materials-stocks-that-could-blast-off-this-month-3">Top 3 Materials Stocks That Could Blast Off This Month</a> </li>
</ul>
Photo via Shutterstock

Intraday Update

Markets

Movers

AIRO

ARQQ

ASTS

CRCL

Hims & Hers Health, Inc. Class A Common Stock

HIMS

MRVL

QUBT

ROKU

SAGE

SATS

TSSI

URGN

Sage Therapeutics, Roku, EchoStar And Other Big Stocks Moving Higher On Monday

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.darlingii.com%2F&amp;esheet=54276132&amp;newsitemid=20250613534574&amp;lan=en-US&amp;anchor=Darling+Ingredients+Inc.&amp;index=1&amp;md5=bf2c7237cfd2ee8c51ba1e89137db9da">Darling Ingredients Inc.</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>) ("Darling" or the "Company") the world's leading company turning food waste into sustainable products and producer of renewable energy today announced that Darling Global Finance B.V. (the "Issuer"), an indirect, wholly owned subsidiary of the Company incorporated as a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid) under Dutch law, has launched an offering of €750 million in aggregate principal amount of its senior notes (the "notes"). In addition, the Company announces that it intends to amend and restate its Second Amended and Restated Credit Agreement, dated as of January 6, 2014 (as amended from time to time), pursuant to a Third Amended and Restated Credit Agreement.
The notes will be guaranteed by the Company and the Company's restricted subsidiaries that will be borrowers under or that will guarantee the Company's senior secured credit facilities under the proposed Third Amended and Restated Credit Agreement, other than foreign subsidiaries, receivables entities and certain other subsidiaries. The offering is subject to market and other conditions.
The Company intends to use the proceeds from the offering of the notes, together with the drawings under the proposed senior secured credit facilities, to (i) redeem the Issuer's €515.0 million principal amount of the 3.625% Senior Notes due 2026 issued under the indenture dated May 2, 2018 and repay certain of the existing senior secured credit facilities; and (ii) pay costs, fees and expenses related to the refinancing, including applicable premiums for the refinancing and the issuance discount for the initial purchasers.

Offerings

Darling Ingredients Launches €750M Debt Offering to Refinance Loans and Strengthen Renewable Energy Push

Among the top mid-cap stocks that gained last week, most were energy stocks, driven by a spike in oil prices fueled by the Middle East conflict.
<ol class="wp-block-list">
<li>Oklo Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>) stock rose 26.59% after the company was issued a <a href="https://www.benzinga.com//node/45909275">Notice of Intent</a> to Award by the Defense Logistics Agency Energy to provide clean power through its Aurora powerhouse for a U.S. Air Force site. It also raised $400 million via an equity offering, and several analysts increased their <a href="https://www.benzinga.com/quote/OKLO/analyst-ratings">price forecasts on the stock</a>.</li>
<li>Bausch Health Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHC#NYSE">BHC</a>) stock increased 25.63% last week.</li>
<li>Quantum Computing, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) stock climbed 21.75% last week after Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) CEO Jensen Huang <a href="https://www.benzinga.com//node/45889749">commented that quantum computers</a> will soon solve real-world problems beyond classical computing, boosting interest in quantum-linked stocks.</li>
<li>Transocean Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIG#NYSE">RIG</a>) stock gained 20.29% last week due to rising oil prices amid heightened geopolitical tensions in the Middle East.</li>
<li>MP Materials Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MP#NYSE">MP</a>) stock rose 18.87% last week after reports that the Trump administration <a href="https://www.benzinga.com//node/45846703">plans to invoke Cold War-era</a> powers to accelerate rare earth projects.</li>
<li>Sasol Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSL#NYSE">SSL</a>) stock increased 18.48% last week.</li>
<li>Darling Ingredients Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>) gained rose 17.11% last week.</li>
<li>Civitas Resources, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIVI#NYSE">CIVI</a>) stock increased 16.77% last week following energy sector momentum driven by surging oil prices and Middle East instability.</li>
<li>PBF Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBF#NYSE">PBF</a>) stock rose 15.41% last week after energy stocks rallied amid rising crude prices and geopolitical conflict.</li>
<li>CVR Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVI#NYSE">CVI</a>) stock gained 14.83% last week after the strength of the oil market lifted energy shares broadly.</li>
</ol>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/06/45940507/oracle-ast-spacemobile-and-halliburton-are-among-top-10-large-cap-gainers-last-week-june-9-13-are-the-others-in-your-portfolio" target="_blank" rel="noreferrer noopener">Oracle, AST SpaceMobile And Halliburton Are Among Top 10 Large Cap Gainers Last Week (June 9-13): Are The Others In Your Portfolio?</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/06/45940506/applovin-chewy-and-carvana-are-among-top-11-large-cap-losers-last-week-june-9-13-are-the-others-in-your-portfolio" target="_blank" rel="noreferrer noopener">AppLovin, Chewy And Carvana Are Among Top 11 Large Cap Losers Last Week (June 9-13): Are The Others In Your Portfolio?</a></li>
</ul>
Photo via Shutterstock

Mid Cap

CIVI

NVDA

OKLO

Oklo, Quantum Computing And Transocean Are Among Top 10 Mid Cap Gainers Last Week (June 9-13): Are The Others In Your Portfolio?

U.S. stocks were lower, with the Dow Jones index falling around 600 points on Friday.
Shares of Unusual Machines, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UMAC#NYSE">UMAC</a>) rose sharply during Friday's session after the company agreed to acquire Rotor Lab in all-stock deal valued at $7 million. The company also announced termination of definitive<a href="https://www.benzinga.com/quote/UMAC"> agreement to acquire Aloft.</a>
Unusual Machines shares jumped 19.5% to $9.85 on Friday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>) shares jumped 22.8% to $217.17 after the company reported better-than-expected first-quarter adjusted EPS results and announced it is maintaining its current FY25 guidance despite tariff and macroeconomic event uncertainty.</li>
<li>AleAnna, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANNA#NASDAQ">ANNA</a>) gained 18.3% to $10.40.</li>
<li>Columbus Circle Capital Corp I (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCCM#NASDAQ">CCCM</a>) rose 13.5% to $11.95.</li>
<li>Darling Ingredients Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>) surged 11.4% to $35.08.</li>
<li>Maase Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAAS#NASDAQ">MAAS</a>) rose 11.1% to $3.00.</li>
<li>Sasol Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSL#NYSE">SSL</a>) gained 10.8% to $5.38.</li>
<li>Celldex Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLDX#NASDAQ">CLDX</a>) climbed 9.9% to $22.36 as the company announced 76-week results from Barzolvolimab Phase 2 study in chronic spontaneous urticaria at EAACI Congress 2025.</li>
<li>UroGen Pharma Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URGN#NASDAQ">URGN</a>) rose 8.4% to $12.01. UroGen Pharma shares traded higher on Thursday after the FDA approved ZUSDURI for intravesical solution as the first and only medication for recurrent low-grade intermediate-risk non-muscle invasive bladder cancer.</li>
<li>DoubleDown Interactive Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDI#NASDAQ">DDI</a>) gained 6.9% to $8.71. DoubleDown Interactive recently announced the pricing of its secondary offering of 4,347,827 ADS by selling shareholders at $8.50 per ADS.</li>
<li>Kosmos Energy Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KOS#NYSE">KOS</a>) gained 6.7% to $2.2309.</li>
<li>Phathom Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAT#NASDAQ">PHAT</a>) gained 5.5% to $10.58.</li>
<li>Bunge Global SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BG#NYSE">BG</a>) rose 5% to $80.89.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45924005/top-2-energy-stocks-that-may-fall-off-a-cliff-in-june">Top 2 Energy Stocks That May Fall Off A Cliff in June</a> </li>
</ul>
Photo via Shutterstock

ANNA

CCCM

CLDX

Highest Performances Holdings Inc. - American Depository Shares

MAAS

PHAT

UMAC

Unusual Machines, Celldex Therapeutics, RH And Other Big Stocks Moving Higher On Friday

Darling Ingredients Announces Dual Listing Of Its Common Stock On NYSE Texas; To Trade Under 'DAR' On NYSE Texas

Darling Ingredients (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>) and Tessenderlo Group disrupted the enormously profitable health, wellness and nutrition industry this week, <a href="https://www.benzinga.com/pressreleases/25/05/b45340702/darling-ingredients-and-tessenderlo-group-agree-to-form-new-company-to-accelerate-growth-in-attrac">announcing an agreement</a> to merge the collagen and gelatin units of their waste recovery operations into the newly formed Nextiva. Darling already produces 30% of the world's collagen supply, while the joint venture could generate up to $1.5 billion in revenue in its first year of operation.&nbsp;
Nextiva will sit in collagen's sweet spot, with industry growth forecast to rise 9.5% annually, reaching over $14 billion in 2033. This biological gold is extracted from animal skin, tendon, cartilage and bone that waste recovery companies used to throw away as useless byproduct. Its popularity in cosmetics, joint health, supplements, biomaterials and pharmaceuticals has exploded in the last decade, with anti-aging and skin health benefits touted by Jennifer Aniston, Kate Hudson, Kourtney Kardashian and other celebrities.
Don't Miss:
<ul class="wp-block-list">
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
Texas-based Darling has struggled in the last two years, with annual revenue dropping from $6.79 billion in fiscal 2023 to $5.22 billion in fiscal 2024. This marked the first revenue downturn for the S&amp;P Mid Cap 400 component since 2019. The hookup is a strategic move to respond to Wall Street about declining performance and regrow earnings by leveraging its leadership in the profitable animal byproducts segment.&nbsp;
Top tier investment firms including Piper Sandler, <a href="https://www.benzinga.com/markets/25/04/45039081/td-cowen-says-twenty-one-reflects-most-meaningful-validation-of-strategys-bitcoin-treasury-operation">TD Cowen</a>, and UBS cover Darling stock but have yet to issue research reports on this week's news. Clearly, their endorsements will help the deal proceed without roadblocks. In late April, Jason Gabelman at TD Cowen lowered his Darling price target from $37 to $34, pointing to an inconsistent track record on guidance. His ‘take' on the new venture will be watched closely by Wall Street.
Chairman and CEO Randall C. Stuewe touted the venture, saying, &#8220;Collagen has represented the fastest-growing area of <a href="https://www.benzinga.com/insights/earnings/25/04/44962097/what-to-expect-from-darling-ingredientss-earnings">Darling Ingredients</a>&#8216; food segment business over the past several years.&#8221; He added that the joint venture will provide a "platform for accelerated product development and growth" and create an opportunity to "unlock significant shareholder value." Darling will own 85% of Nextiva, according to the release, while its Brussels partner holds the balance. Together they intend to operate 23 facilities on four continents, producing about 200,000 tons of collagen and gelatin in the first year.&nbsp;
Trending: Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a>
The hookup is not expected to close until 2026. The initial press release describes the venture as a noncash transaction that combines assets and capabilities, but negotiations are continuing, and no definitive documentation has been sign by principals. However, the ownership ratio between the much larger Darling and its smaller partner appears locked-in and there are no obvious red flags to the startup currently.
Nextiva will also require regulatory approval in the U.S. and European Union, which might face unexpected hurdles, given current political tensions. Meanwhile, collagen use remains unregulated and somewhat controversial, <a href="https://www.health.harvard.edu/blog/considering-collagen-drinks-and-supplements-202304122911">with critics noting the refined product</a> used in supplements breaks down when ingested, rather than rebuilding our naturally produced substance. They also point to the corruptive influence of marketing hype, driven by celebrities owning companies benefiting from collagen use.
Regardless, both critics and advocates consider collagen use to be safe and our beauty-obsessed culture has a long history of chasing the latest ‘Fountain of Youth', regardless of cost. This bodes well for Darling and Tessenderlo's profit growth in coming years. And, given their giant industry footprint, they could strongly influence worldwide supply and pricing in coming decades.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a></li>
<li>The team behind $6B+ in licensing deals is now building the next billion-dollar IP empire — <a href="https://www.benzinga.com/money/elf-labs-ym?v=123">invest early at $2.25/share.</a></li>
</ul>
Image: Shutterstock

New Wellness JV Nexida Aims to Tackle Aging—And They're Backed by a Third of the World's Collagen Supply

<ul>
<li>Creates ~$1.5 billion revenue company in fast-growing collagen-based health, nutrition and food sectors</li>
<li>85% owned and consolidated by Darling Ingredients</li>
<li>Non-cash transaction, combining assets, capabilities</li>
<li>Strengthens foundation around serving food and pharma customers</li>
<li>Provides a platform for accelerated product development and growth</li>
<li>Creates an opportunity to unlock significant shareholder value</li>
</ul>

Darling Ingredients (85%) And Tessenderlo Group (15%) To Merge Collagen Units Into $1.5B Global Venture Nextida

Baird analyst Ben Kallo maintains Darling Ingredients (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>) with a Outperform and lowers the price target from $41 to $40.

Baird Maintains Outperform on Darling Ingredients, Lowers Price Target to $40

Press Releases

Darling Ingredients Inc. to Release First Quarter 2025 Financial Results

Darling Ingredients Inc. Reports First Quarter 2025 Results

Darling Ingredients Inc. to Participate in BMO Global Farm to Market Conference

Darling Ingredients and Tessenderlo Group Agree to Form New Company to Accelerate Growth in Attractive Collagen-Based Health, Wellness and Nutrition Sector

Darling Ingredients Inc. Announces Dual Listing on NYSE Texas

Darling Ingredients Inc. announces offering of €750 Million of senior notes by Darling Global Finance B.V. and proposed entry into a new amended and restated credit agreement

Darling Ingredients Inc. Announces Pricing of Offering of €750 Million of Senior Notes Due 2032 by Darling Global Finance B.V.

Darling Ingredients Inc. announces offering of €750 million of senior notes by Darling Global Finance B.V., entry into a new amended and restated credit agreement, and redemption of €515.0 million 3.625% senior notes due 2026

Darling Ingredients Inc. to Release Second Quarter 2025 Financial Results

Darling Ingredients Inc. Reports Second Quarter 2025 Results

Archer-Daniels-Midland Company Common Stock

Archer-Daniels-Midland

AgriFORCE Growing Systems Ltd. - Common Shares

AgriFORCE Growing Systems

Alico

Bunge Global

CHS Inc - Class B Cumulative Redeemable Preferred Stock, Series 4

7.50% PRF PERPETUAL USD 25 - Class B Ser 4

CHS Inc - Class B Reset Rate Cumulative Redeemable Preferred Stock, Series 3

CHS Inc - Preferred Class B Series 2 Reset Rate

CHS Inc - Class B Cumulative Redeemable Preferred Stock

CHS Inc - 8% Cumulative Redeemable Preferred Stock

Cresud S.A.C.I.F. y A. - American Depositary Shares, each representing ten shares of Common Stock

Comments

Darling Ingredients

Intérêt court

Darling Ingredients (NYSE:DAR) Stock, Rapport sur les intérêts à découvert

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL